Developmental Medicine & Child Neurology · 2004 · 33 citations · 7 references
MedicineNeurologyPediatricsMovement DisordersNeurogeneticsNeuromuscular DisordersEnzyme DeficienciesMitochondrial Neurological DisordersMovement Disorder GeneticsNeurogenetic DisordersBiochemical Deficiency DiagnosisDystonia SyndromesEnzyme Deficiency DisordersPediatric Dystonia GeneticsPyruvate Dehydrogenase Complex DeficiencyPyruvate Dehydrogenase DeficiencyPyruvate Kinase DeficiencyPyruvate Metabolism
Two individuals with pyruvate dehydrogenase (PDH) deficiency due to missense mutations in the gene for the E1alpha subunit (PDHA1) presented during childhood with dystonia. The first patient, a male, presented at age 4 years with dystonia affecting the lower limbs, which responded to treatment with combined carbidopa and levodopa. The second patient, a female, was first investigated at age 6 years because of a dystonic gait disorder. In both patients, the main clue to the biochemical diagnosis was a raised concentration of lactate in the cerebrospinal fluid. PDH activity was significantly reduced in cultured fibroblasts in both cases. Dystonia is a previously unrecognized major manifestation of PDH deficiency and is of particular interest as the mutations in the PDHA1 gene in these patients have both been identified previously in individuals with typical presentations of the condition.
7
Leigh syndrome: Clinical features and biochemical and DNA abnormalities
S. Rahman, Rozanne B. Blok, H H Dahl et al. · Annals of Neurology · 1996 · 780 citations
Immunochemical analysis of normal and mutant forms of human pyruvate dehydrogenase
Carol Wicking, R. D. Scholem, S. M. Hunt et al. · Biochemical Journal · 1986 · 88 citations · Full text
Kathy Chun, N. MacKay, Roumyana Petrova-Benedict et al. · PubMed · 1995 · 53 citations